Recombinant human GFRA3 (Sf9) protein

(HB6843)
Technical documents: Datasheet

Product overview

Name Recombinant human GFRA3 (Sf9) protein
Alternative names Recombinant Human GDNF Family Receptor Alpha 3, Sf9, GDNF Family Receptor Alpha3, GDNFR-alpha-3, GFR-alpha-3, GDNF Receptor Alpha-3, GDNFR3, GDNF Family Receptor Alpha-3, Glial Cell Line-Derived Neurotrophic Factor Receptor Alpha-3, GPI-Linked Receptor, GFRA3.
Purity >85%
Description Recombinant human GDNF receptor alpha-3 protein from Sf9 Baculovirus cells
Write Your Own Review
You're reviewing:Recombinant human GFRA3 (Sf9) protein
Rate this item:

Solubility & Handling

Handling
  • Solutions should be made in sterile deionized water (not less than 100 µg/ml). This solution can then be further diluted with other aqueous solutions.
  • Following reconstitution, solutions may be stored at 4°C and are useable for around 2-7 days and for future use store at -18°C.
  • For long term storage, a carrier protein (0.1% HSA or BSA) should be added to stock solutions. Solutions should be aliquoted into tightly sealed vials for storage at -20°C. Freeze-thaw cycles should be prevented.
Shipping Conditions Stable for ambient temperature shipping. Follow storage instructions on receipt.
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >85%
UniProt ID O60609
Source Sf9, Baculovirus cells.
Structure image  Chemical Structure
Appearance Clear solution (sterile filtered)
Formulation Solution (0.25mg/ml) containing PBS (pH7.4) and 10% glycerol

References for Recombinant human GFRA3 (Sf9) protein

References are publications that support the biological activity of the product
  • Biology of GDNF and its receptors - Relevance for disorders of the central nervous system

    Ibanez CF et al (2017) Neurobiol Dis 97(Pt B) : 80-89
  • Glial cell line-derived neurotrophic factor (GDNF) induces neuritogenesis in the cochlear spiral ganglion via neural cell adhesion molecule (NCAM)

    Euteneuer S et al (2013) Mol Cell Neurosci 54 : 30-43
  • Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease

    Grondin R et al (1998) J Neurol 245(11 Suppl 3) : P35-42

3 Item(s)